“The FDA’s Vaccines and Related Biological Products Advisory Committee is holding a virtual meeting Tuesday, October 26 to discuss authorizing a Pfizer-BioNTech Coronavirus vaccine for children between the ages of 5 to 11 years old. This committee has a lot of sway with the FDA and their findings will be relevant, considering the Biden administration is getting ready to ship vaccines to elementary schools and California has already mandated the vaccine for schoolchildren pending federal authorization.”
Read Our Latest News
Do you like this post?
Showing 1 reaction